Why the study?
Does hemodialysis affect plasma norepinephrine, epinephrine, and dopamine levels in patients with end-stage renal disease?
Does hemodialysis affect plasma norepinephrine, epinephrine, and dopamine levels in patients with end-stage renal disease?
Hemodialysis significantly alters plasma catecholamine levels, which must be accounted for when evaluating hypertensive patients with end-stage renal disease.
The effect of hemodialysis on plasma norepinephrine (NE), epinephrine, and dopamine levels was studied in 11 patients undergoing maintenance hemodialysis. The results showed that the baseline plasma concentrations of NE and dopamine were significantly elevated in patients with end-stage renal disease undergoing maintenance hemodialysis. Intradialysis weight loss and fall in the serum glucose concentration during dialysis correlated with changes in plasma epinephrine and NE concentrations. Single-pass dialysis resulted in a marked reduction in the plasma NE concentration, indicating significant removal by dialysis. These observations should be taken into consideration when interpreting plasma catecholamine data obtained in the course of investigation of hypertensive patients with end-stage renal disease.
No takes yet. Share an insight, caveat, or question.
Alan N. Elias (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: